UnknownPhase 2NCT00084695
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Studying Acute myeloid leukemia with recurrent genetic anomaly
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Milton S. Hershey Medical Center
- Principal Investigator
- Kenneth G. Lucas, MDMilton S. Hershey Medical Center
- Intervention
- anti-thymocyte globulin(biological)
- Enrollment
- 25 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2003
Study locations (1)
- Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00084695 on ClinicalTrials.govOther trials for Acute myeloid leukemia with recurrent genetic anomaly
Additional recruiting or active studies for the same condition.
See all trials for Acute myeloid leukemia with recurrent genetic anomaly →